BÁO CÁO Y HỌC: "DELTA INFLATION: A BIAS IN THE DESIGN OF RANDOMIZED CONTROLLED TRIALS IN CRITICAL CARE MEDICINE" PPSX
Tìm thấy 10,000 tài liệu liên quan tới tiêu đề "BÁO CÁO Y HỌC: "DELTA INFLATION: A BIAS IN THE DESIGN OF RANDOMIZED CONTROLLED TRIALS IN CRITICAL CA...":
Cirrhosis), is a multicenter study of the potential benefit of prolonged peginterferon therapy in mitigating the progression of fibrotic liver disease. [8] In this study, 391 of the 1045 patients enrolled into the initial “lead-in” phase had biopsy proven cirrhosis. Preliminary results show t[r]
Cirrhosis), is a multicenter study of the potential benefit of prolonged peginterferon therapy in mitigating the progression of fibrotic liver disease. [8] In this study, 391 of the 1045 patients enrolled into the initial “lead-in” phase had biopsy proven cirrhosis. Preliminary results show t[r]
associated with whole-body insulin sensitivity such as CRP and pro-inflammatory cytokines [20]. A few recent studies have investigated exercise training on circulating adiponectin levels. These studies have shown that greater increases in adiponectin levels are associated with higher intensit[r]
among natural weight loss supplements. Theoretically, they may promote weight loss by interfering with the breakdown of complex carbohydrates thereby reducing, or at least slowing, the digestive availability of carbo-hydrate-derived calories and/or by providing resistant starches to the lower gastro[r]
recipients. Clinical Gastroenterol Hepatol. 2005; 10:S125-31 19. Lee W, Dieterich D. Challenges in the management of HIV and hepatitis C virus infection. Drugs. 2004;64(7):693-700 20. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with Human Immuno[r]
pattern. It is possible that participants who have been diagnosed with a chronic disease may have changed their diet. To address this concern we adjusted for the presence of chronic disease (CHD, cancer, and stroke) and hypertension throughout the analyses. We also repeated the analyses exclu[r]
subjects walked briskly for 20 minutes at 45-80% heart rate (HR) reserve (to achieve an intensity of 11-14 of Rating of Perceived Exertion Scale), more than 5 days a week. They also performed a 30 minute resistance training (3 times per week) consisting of a 5-minute warm-up and[r]
2005; 352(20):2049–2060. 15. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005; 142(7):497–505. 16. Mooradian AD. Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques an[r]
of general populations [8, 9], and as high as 30% of the population aged 65 and older in the Framingham Heart Study (tHcy > 14 nmol/ml) [10]. Increasing tHcy concentrations accelerate cardiovascular diseases by promoting vascular inflammation, endothelial dys-function, and hypercoagulability[r]
To the best of our knowledge, we are reporting the first case in which an epithelial component of phyllodes tumor is identical to that of a tubular adenoma of the breast. And this is in addition to very rare liposarcomatous stromal differentiation in malignant phyllodes tumor. This tumor does[r]
it possible to collect a large number of pregnancies where the women used a drug (prescription or over-the counter) and to study offspring for various characteristics, including congenital malformations. Outcome is based on the recording of the attending paediatrician. It is known that[r]
changing of culture media and serial passage. Additionally, there is also a possibility of hESC being exposed to low temperature for an extended duration of time, during infrequent occurrences of incubator break-down and power failure. Hence, it is imperative to characterize the low temperatu[r]
118mouse embryonic stem (ES) cells carrying targeted mutations of BRCA1 (homozygous deletion of exons 22-24, referred to as BRCA1-/-) or BRCA2 (trEx11/ΔEx27, referred to as BRCA2-/-), Farmer et al. (2005) revealed similar sensitivity of these cells to PARP-1 inhibitors in vitro [25]. Will this work[r]
Int. J. Med. Sci. 2006, 3 1114. Skogsberg J, Kannisto R, Roshani L, Gagne E, Hamsten A, Larsson C, Ehrenborg E. Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. Int J Mol Med. 2000; 6: 73-81. 5. Olivier WR, Shenk JL, Snaith MR, Russell CS[r]